Xenomorph, the analytics and data management solutions provider to global financial institutions, has been named a finalist in five categories in the 2014 Data Management Summit (DMS) Award by the A-Team Group, a leading financial technology organization.
The annual DMS Awards recognize outstanding products and services in data management and are selected by A-Team Group’s editorial staff through a poll of key industry contacts and practitioners. For the second consecutive year, Xenomorph’s TimeScape has been nominated in multiple categories in the DMS Awards as a result of the innovative advances and quality service the firm offers. This year, Xenomorph was selected in the following five categories: “Best Sell-Side Enterprise Data Management Platform,” “Best Buy-Side Enterprise Data Management Platform,” “Best Enterprise Data Management Platform (Portfolio Pricing & Valuations),” “Best Risk Data Aggregation Platform” and “Best Analytics Platform.”
“Having been nominated across multiple categories is an incredible honour and recognition of Xenomorph’s on-going commitment to empower buy- and sell-side firms to best manage vast amounts of data and the necessary processes to keep pace with an increasingly complex regulatory and compliance landscape,” said Brian Sentance, CEO, Xenomorph. “In 2014, our focus has remained on continued innovation of the TimeScape platform, which now offers clients a cloud-based option to integrate the same high quality, consistent and complete datasets they are accustomed to across all their core systems.”
Xenomorph provides a sophisticated data management solution to offer market-leading analytics that can be applied to all asset classes. The firm’s nomination for the awards is a direct recognition of the expertise and significant success demonstrated by Xenomorph’s offering in the past year.
Voting is open to the industry, and will close on Friday, Sept. 26, 2014. Award winners will be announced at A-Team’s Data Management Summit, to be held Oct. 8, 2014, at the America Square Conference Centre in London.